These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32376084)
1. Radioarsenic: A promising theragnostic candidate for nuclear medicine. Sanders VA; Cutler CS Nucl Med Biol; 2021 Jan; 92():184-201. PubMed ID: 32376084 [TBL] [Abstract][Full Text] [Related]
2. Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals. DeGraffenreid AJ; Feng Y; Barnes CL; Ketring AR; Cutler CS; Jurisson SS Nucl Med Biol; 2016 May; 43(5):288-95. PubMed ID: 27150031 [TBL] [Abstract][Full Text] [Related]
3. Radioarsenic from a portable (72)Se/(72)As generator: a current perspective. Ballard B; Nortier FM; Birnbaum ER; John KD; Phillips DR; Fassbender ME Curr Radiopharm; 2012 Jul; 5(3):264-70. PubMed ID: 22697482 [TBL] [Abstract][Full Text] [Related]
4. High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals. Ellison PA; Barnhart TE; Chen F; Hong H; Zhang Y; Theuer CP; Cai W; Nickles RJ; DeJesus OT Bioconjug Chem; 2016 Jan; 27(1):179-88. PubMed ID: 26646989 [TBL] [Abstract][Full Text] [Related]
5. Paving the way to personalized medicine: production of some promising theragnostic radionuclides at Brookhaven National Laboratory. Srivastava SC Semin Nucl Med; 2012 May; 42(3):151-63. PubMed ID: 22475424 [TBL] [Abstract][Full Text] [Related]
6. Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine. Whetter JN; Śmiłowicz D; Boros E Acc Chem Res; 2024 Mar; 57(6):933-944. PubMed ID: 38501206 [TBL] [Abstract][Full Text] [Related]
14. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept. Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573 [TBL] [Abstract][Full Text] [Related]
15. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Jennewein M; Lewis MA; Zhao D; Tsyganov E; Slavine N; He J; Watkins L; Kodibagkar VD; O'Kelly S; Kulkarni P; Antich PP; Hermanne A; Rösch F; Mason RP; Thorpe PE Clin Cancer Res; 2008 Mar; 14(5):1377-85. PubMed ID: 18316558 [TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
17. Use of radioiodine in nuclear medicine-A brief overview. Ferris T; Carroll L; Jenner S; Aboagye EO J Labelled Comp Radiopharm; 2021 Mar; 64(3):92-108. PubMed ID: 33091159 [TBL] [Abstract][Full Text] [Related]
18. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine. Haddad F; Ferrer L; Guertin A; Carlier T; Michel N; Barbet J; Chatal JF Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1377-87. PubMed ID: 18465127 [TBL] [Abstract][Full Text] [Related]